Development and validation of serological markers for detecting recent Plasmodium vivax infection

Journal: Nature Medicine

Published: 2020-05-11

DOI: 10.1038/s41591-020-0841-4

Affiliations: 21

Authors: 27

Go to article
Institutions Share
Division of Population Health and Immunity, WEHI, Australia 0.11
Division of Malaria Research, Ehime University, Japan 0.11
Department of Medical Biology, UniMelb, Australia 0.11
Foundation for Innovative New Diagnostics (FIND), Switzerland 0.07
Laboratory of Malaria Parasite Biology and Vaccines, Pasteur Institute, France 0.07
Department of Parasites and Insect Vectors, Pasteur Institute, France 0.07
CellFree Sciences Co., Ltd., Japan 0.06
Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand 0.05
Division of Infection and Immunity, WEHI, Australia 0.04
Faculty of Tropical Medicine, MU, Thailand 0.04
Tropical Medicine Foundation Doctor Heitor Vieira Dourado (FMT-HVD), Brazil 0.04
Instituto Nacional de Infectologia (INI) / Instituto de Pesquisa Clínica Evandro Chagas (IPEC), FIOCRUZ, Brazil 0.04
Center for Global Health and Diseases, CWRU, United States of America (USA) 0.04
Centre for Molecular Therapeutics (CMT), JCU, Australia 0.02
Australian Institute of Tropical Health and Medicine (AITHM), JCU, Australia 0.02
QIMR Berghofer Medical Research Institute, Australia 0.02
RIKEN Center for Integrative Medical Sciences (IMS), Japan 0.02
Center of Bioinformatics, Biostatistics and Integrative Biology (C3BI), France 0.02
University of the State of Amazonas (UEA), Brazil 0.02
Instituto Leônidas e Maria Deane, FIOCRUZ, Brazil 0.02
Burnet Institute, Australia 0.01